Thomas Struengmann

About Thomas Struengmann:

Thomas Struengmann is a German entrepreneur and investor, born on January 6, 1950, in Wuerzburg, Germany. Along with his twin brother Andreas Struengmann, he co-founded the pharmaceutical company Hexal AG in 1986, which they sold to the Swiss pharmaceutical giant Novartis for €5.65 billion in 2005.

After the sale of Hexal AG, Thomas and Andreas Struengmann established Athos Service GmbH, which manages their investments in the healthcare industry. Through Athos Service, they have invested in several pharmaceutical and biotech companies, including BioNTech, which played a pivotal role in developing the first COVID-19 vaccine in collaboration with Pfizer.

Apart from their investments, Thomas and Andreas Struengmann are also known for their philanthropy. They have established the Struengmann Foundation, which supports scientific research in the fields of medicine, life sciences, and the humanities. They have also donated significant amounts of money to various institutions, including the Max Planck Society, the University of Frankfurt, and the Technical University of Munich.

Thomas Struengmann Net Worth:

Thomas Struengmann's net worth was estimated to be around $17.7 billion USD according to Forbes' real-time billionaire tracker. However, it's important to note that net worth can fluctuate depending on various factors such as stock prices, business deals, and economic conditions. Additionally, it's difficult to provide an accurate current estimate as net worth can change rapidly and frequently.

Thomas Struengmann Net Worth in Rupees:

Thomas Struengmann Education:

Thomas Struengmann Life Style:

I do not have access to Thomas Struengmann's personal life, but based on publicly available information, he is known for leading a relatively low-profile life. He and his brother Andreas are known for being highly focused on their investments and philanthropic work. They are reported to live in Frankfurt, Germany, and are known to keep a low profile and avoid the media spotlight. However, they are active supporters of various charitable causes, including scientific research and education, and have donated significant amounts of money to these causes. In terms of his personal style, Thomas Struengmann is known for being highly disciplined and hardworking, with a focus on achieving long-term success through careful planning and strategic investments.

Thomas Struengmann Companies:

Thomas Struengmann is known for co-founding and investing in various pharmaceutical and biotech companies. Some of the notable companies associated with him include:

1. Hexal AG - a German pharmaceutical company that he co-founded with his brother Andreas Struengmann in 1986. The company became one of the largest generics drug manufacturers in Europe before it was sold to Novartis in 2005 for €5.65 billion.

2. BioNTech SE - a biotechnology company that develops immunotherapies for the treatment of cancer and infectious diseases. Thomas and Andreas Struengmann invested in the company through their investment vehicle Athos Service GmbH, and BioNTech played a pivotal role in developing the first COVID-19 vaccine in collaboration with Pfizer.

3. Ganymed Pharmaceuticals AG - a German biotech company that develops therapeutic antibodies for the treatment of cancer. The Struengmann brothers invested in the company and sold it to Astellas Pharma in 2016 for €1.28 billion.

4. Wilex AG - a German biotech company that develops antibodies for the treatment of cancer. The Struengmann brothers invested in the company and sold their shares to Heidelberg Pharma in 2019.

5. Molecular Partners AG - a Swiss biotech company that develops protein therapeutics for the treatment of cancer and other diseases. The Struengmann brothers invested in the company and served on its board of directors.

These are just a few examples of the many companies that Thomas Struengmann has been associated with over the course of his career in the pharmaceutical and biotech industries.

Thomas Struengmann Family Background:

Thomas Struengmann was born in Wuerzburg, Germany on January 6, 1950, along with his identical twin brother Andreas Struengmann. Their father was a chemical engineer and their mother was a teacher. Thomas and Andreas grew up in Wuerzburg and attended local schools before going on to study medicine at the Julius Maximilian University of Würzburg.

Not much is publicly known about Thomas Struengmann's family background beyond his parents and twin brother. However, it is clear that he and his brother have been close collaborators throughout their careers, co-founding and investing in various pharmaceutical and biotech companies together. The Struengmann brothers are also known for their philanthropy, having established the Struengmann Foundation to support scientific research and other charitable causes.

How Much Money Does Thomas Struengmann Have:

Thomas Struengmann's net worth was estimated to be around $17.7 billion USD according to Forbes' real-time billionaire tracker. However, it's important to note that net worth can fluctuate depending on various factors such as stock prices, business deals, and economic conditions.